Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure

J. M. Jozine Ter Maaten, A. A. Voors, M. Metra, P. Van Der Harst, K. Dickstein, F. Zannad, J. G. Cleland, H. L. Hillege, K. Damman, M. H. De Borst

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Article number674
Pages (from-to)161-161
Number of pages1
JournalEuropean Journal of Heart Failure
Publication statusPublished - May-2016

Cite this